We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
iRobot (IRBT) Q1 Earnings: What's in Store for the Stock?
Read MoreHide Full Article
iRobot Corporation (IRBT - Free Report) is scheduled to report its first-quarter 2017 earnings after the opening bell on Apr 25, 2017.
Bedford, MA-based iRobot is one of the leading manufacturers of robots worldwide. The company is a leader not only in the domestic arena but also in the field of commercial usage.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
iRobot expects to generate higher revenues in the quarter on the back of stunning market response to new wet floor category products, stronger demand in the Smart Home market, increased penetration of Roomba in the U.S., solid business in certain niche overseas markets like Japan and higher sales of Braava in Asia.
Notably, iRobot is poised to grow on the back of meaningful innovations, strategic marketing programs and diligent restructuring initiatives.
However, the company relies on single source contract manufacturers and hence, its brand status and business performance are both highly dependent on them. For instance, almost all the contract manufacturers of iRobot’s home robotic products belong to China.
iRobot conducts its business in a highly dynamic and competitive technology market. Prominent product or process innovation of major industry rivals might adversely impact its market share in the future. Moreover, the company’s future commercial success highly depends on its ability to penetrate in the consumer home-care market. Hence, iRobot makes constant efforts to reinforce its consumer robotics trade by developing new products at competitive prices. However, such developments involve a lot of risk, cost and time. Inability to introduce new products or deliver the same within appropriate time might considerably hurt the company’s top-line growth in the quarters ahead.
Earnings Whispers
Our proven model does not conclusively show that iRobot is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as we will see below.
Zacks ESP: iRobot currently has an Earnings ESP of -3.85%. This is because the Zacks Consensus Estimate of 26 cents is higher than the Most Accurate estimate of 25 cents.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: iRobot’s Zacks Rank #3 increases the predictive power of ESP. However, we need to have a positive ESP to be confident about an earnings surprise.
Note that we caution against Sell-rated stocks (Zacks Rank #4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are some companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:
Anixter International Inc. , with an Earnings ESP of +2% and a Zacks Rank #3.
C.H. Robinson Worldwide, Inc. (CHRW - Free Report) , with an Earnings ESP of +2.50% and a Zacks Rank #3.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
iRobot (IRBT) Q1 Earnings: What's in Store for the Stock?
iRobot Corporation (IRBT - Free Report) is scheduled to report its first-quarter 2017 earnings after the opening bell on Apr 25, 2017.
Bedford, MA-based iRobot is one of the leading manufacturers of robots worldwide. The company is a leader not only in the domestic arena but also in the field of commercial usage.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
iRobot expects to generate higher revenues in the quarter on the back of stunning market response to new wet floor category products, stronger demand in the Smart Home market, increased penetration of Roomba in the U.S., solid business in certain niche overseas markets like Japan and higher sales of Braava in Asia.
Notably, iRobot is poised to grow on the back of meaningful innovations, strategic marketing programs and diligent restructuring initiatives.
However, the company relies on single source contract manufacturers and hence, its brand status and business performance are both highly dependent on them. For instance, almost all the contract manufacturers of iRobot’s home robotic products belong to China.
iRobot conducts its business in a highly dynamic and competitive technology market. Prominent product or process innovation of major industry rivals might adversely impact its market share in the future. Moreover, the company’s future commercial success highly depends on its ability to penetrate in the consumer home-care market. Hence, iRobot makes constant efforts to reinforce its consumer robotics trade by developing new products at competitive prices. However, such developments involve a lot of risk, cost and time. Inability to introduce new products or deliver the same within appropriate time might considerably hurt the company’s top-line growth in the quarters ahead.
Earnings Whispers
Our proven model does not conclusively show that iRobot is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as we will see below.
Zacks ESP: iRobot currently has an Earnings ESP of -3.85%. This is because the Zacks Consensus Estimate of 26 cents is higher than the Most Accurate estimate of 25 cents.
iRobot Corporation Price and EPS Surprise
iRobot Corporation Price and EPS Surprise | iRobot Corporation Quote
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: iRobot’s Zacks Rank #3 increases the predictive power of ESP. However, we need to have a positive ESP to be confident about an earnings surprise.
Note that we caution against Sell-rated stocks (Zacks Rank #4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are some companies you may want to consider as our model shows that these have the right combination of elements to post an earnings beat:
Caterpillar Inc. (CAT - Free Report) , with an Earnings ESP of +9.84% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Anixter International Inc. , with an Earnings ESP of +2% and a Zacks Rank #3.
C.H. Robinson Worldwide, Inc. (CHRW - Free Report) , with an Earnings ESP of +2.50% and a Zacks Rank #3.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>